Haemonetics: Leading Blood‑Processing Innovation & Strong Stock MomentumExplore Haemonetics: Boston‑based leader in automated blood processing, $4.81 B market cap, high P/E, and global tech innovation.HAEMONETICS CORP/MASS Health Care Health Care Equipment & Services AI generated 30/09/2026, 22:16 2 minutes to read
